Explainable artificial intelligence: A taxonomy and guidelines for its application to drug discovery

[1]  S. Cha,et al.  Toward Multiple Specialty Learners for Explaining GNNs via Online Knowledge Distillation , 2022, ArXiv.

[2]  Adam Pacławski,et al.  Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT1A Receptor Case , 2022, Pharmaceutics.

[3]  Craig J. Neal,et al.  AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification , 2022, Briefings Bioinform..

[4]  Salma Jamoussi,et al.  Merits of Bayesian networks in overcoming small data challenges: a meta-model for handling missing data , 2022, International Journal of Machine Learning and Cybernetics.

[5]  Alexander J. Karran,et al.  Designing for Confidence: The Impact of Visualizing Artificial Intelligence Decisions , 2022, Frontiers in Neuroscience.

[6]  Marco Tulio Ribeiro,et al.  ExSum: From Local Explanations to Model Understanding , 2022, NAACL.

[7]  Jinn-Moon Yang,et al.  Discovery of moiety preference by Shapley value in protein kinase family using random forest models , 2022, BMC Bioinformatics.

[8]  M. Tachikawa,et al.  Collaborative Approach between Explainable Artificial Intelligence and Simplified Chemical Interactions to Explore Active Ligands for Cyclin-Dependent Kinase 2 , 2022, ACS omega.

[9]  Hojung Nam,et al.  DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions , 2022, Journal of Cheminformatics.

[10]  Dominic D. Martinelli.  Generative machine learning for de novo drug discovery: A systematic review , 2022, Comput. Biol. Medicine.

[11]  Joseph D. Romano,et al.  Knowledge-guided deep learning models of drug toxicity improve interpretation , 2022, bioRxiv.

[12]  Yuedong Yang,et al.  Structure-Aware Multimodal Deep Learning for Drug-Protein Interaction Prediction , 2022, J. Chem. Inf. Model..

[13]  Hojung Nam,et al.  Sequence-based prediction of protein binding regions and drug–target interactions , 2022, Journal of Cheminformatics.

[14]  Yang Su,et al.  An Accurate and Interpretable Deep Learning Model for Environmental Properties Prediction Using Hybrid Molecular Representations , 2022, AIChE Journal.

[15]  Mobyen Uddin Ahmed,et al.  A Systematic Review of Explainable Artificial Intelligence in Terms of Different Application Domains and Tasks , 2022, Applied Sciences.

[16]  C. Grebner,et al.  Interpretation of Structure-Activity Relationships in Real-World Drug Design Data Sets Using Explainable Artificial Intelligence , 2022, J. Chem. Inf. Model..

[17]  G. D. Fabritiis,et al.  PlayMolecule Glimpse: Understanding Protein–Ligand Property Predictions with Interpretable Neural Networks , 2022, J. Chem. Inf. Model..

[18]  J. Bajorath,et al.  Explainable Machine Learning for Property Predictions in Compound Optimization. , 2021, Journal of medicinal chemistry.

[19]  Luca Longo,et al.  Notions of explainability and evaluation approaches for explainable artificial intelligence , 2021, Inf. Fusion.

[20]  A. Bender,et al.  Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges. , 2021, Methods in molecular biology.

[21]  Dimitar Hristozov,et al.  Deep Learning and Computational Chemistry. , 2021, Methods in molecular biology.

[22]  J. Bajorath,et al.  Explainable machine learning predictions of dual-target compounds reveal characteristic structural features , 2021, Scientific Reports.

[23]  Junzhou Huang,et al.  Application advances of deep learning methods for de novo drug design and molecular dynamics simulation , 2021, WIREs Computational Molecular Science.

[24]  C. Nantasenamat,et al.  ABCpred: a webserver for the discovery of acetyl- and butyryl-cholinesterase inhibitors , 2021, Molecular diversity.

[25]  Y. Tseng,et al.  Ensemble modeling with machine learning and deep learning to provide interpretable generalized rules for classifying CNS drugs with high prediction power , 2021, Briefings Bioinform..

[26]  Nils Weskamp,et al.  Benchmarking Molecular Feature Attribution Methods with Activity Cliffs , 2021, J. Chem. Inf. Model..

[27]  Canqun Yang,et al.  Drug-drug interaction extraction from biomedical texts based on multi-attention mechanism , 2021, ICBRA.

[28]  Gülsüm Alicioğlu,et al.  A survey of visual analytics for Explainable Artificial Intelligence methods , 2021, Comput. Graph..

[29]  Frederick Klauschen,et al.  Explaining Bayesian Neural Networks , 2021, ArXiv.

[30]  Suresh Dara,et al.  Machine Learning in Drug Discovery: A Review , 2021, Artificial Intelligence Review.

[31]  Matteo Manica,et al.  Trends in Deep Learning for Property-driven Drug Design. , 2021, Current medicinal chemistry.

[32]  Connor W. Coley,et al.  Evidential Deep Learning for Guided Molecular Property Prediction and Discovery , 2021, ACS central science.

[33]  J. Bajorath,et al.  Feature importance correlation from machine learning indicates functional relationships between proteins and similar compound binding characteristics , 2021, Scientific reports.

[34]  Lei Deng,et al.  DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations , 2021, bioRxiv.

[35]  Jiahua Rao,et al.  Quantitative evaluation of explainable graph neural networks for molecular property prediction , 2021, Patterns.

[36]  Daniele Regoli,et al.  Counterfactual Explanations as Interventions in Latent Space , 2021, Data Mining and Knowledge Discovery.

[37]  Guadalupe Gonzalez,et al.  Predicting anticancer hyperfoods with graph convolutional networks , 2021, Human genomics.

[38]  Gesina Schwalbe,et al.  A comprehensive taxonomy for explainable artificial intelligence: a systematic survey of surveys on methods and concepts , 2021, Data Mining and Knowledge Discovery.

[39]  U. Deva Priyakumar,et al.  LigGPT: Molecular Generation using a Transformer-Decoder Model , 2021 .

[40]  Sen Song,et al.  An effective self-supervised framework for learning expressive molecular global representations to drug discovery , 2021, Briefings Bioinform..

[41]  Tomoki Suzuki,et al.  Feature importance of machine learning prediction models shows structurally active part and important physicochemical features in drug design. , 2021, Drug metabolism and pharmacokinetics.

[42]  F. Hu,et al.  Multi-PLI: interpretable multi‐task deep learning model for unifying protein–ligand interaction datasets , 2021, Journal of Cheminformatics.

[43]  Ruth Nussinov,et al.  MSA-Regularized Protein Sequence Transformer toward Predicting Genome-Wide Chemical-Protein Interactions: Application to GPCRome Deorphanization , 2021, J. Chem. Inf. Model..

[44]  Sun Kim,et al.  A review on compound-protein interaction prediction methods: Data, format, representation and model , 2021, Computational and structural biotechnology journal.

[45]  C. Ouyang,et al.  Counterfactuals and Causability in Explainable Artificial Intelligence: Theory, Algorithms, and Applications , 2021, Inf. Fusion.

[46]  Zheng Cheng,et al.  Transferable Multilevel Attention Neural Network for Accurate Prediction of Quantum Chemistry Properties via Multitask Learning , 2021, J. Chem. Inf. Model..

[47]  Shuiwang Ji,et al.  Explainability in Graph Neural Networks: A Taxonomic Survey , 2020, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[48]  M. Bianchini,et al.  Molecular graph generation with Graph Neural Networks , 2020, arXiv.org.

[49]  G. Schneider,et al.  Coloring Molecules with Explainable Artificial Intelligence for Preclinical Relevance Assessment , 2020, J. Chem. Inf. Model..

[50]  Michelangelo Ceci,et al.  Semi-supervised regression trees with application to QSAR modelling , 2020, Expert Syst. Appl..

[51]  Bo Zong,et al.  Parameterized Explainer for Graph Neural Network , 2020, NeurIPS.

[52]  Jianzhu Ma,et al.  Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells. , 2020, Cancer cell.

[53]  My T. Thai,et al.  PGM-Explainer: Probabilistic Graphical Model Explanations for Graph Neural Networks , 2020, NeurIPS.

[54]  Jimeng Sun,et al.  SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization , 2020, Bioinform..

[55]  Matthias Rarey,et al.  SMARTS.plus – A Toolbox for Chemical Pattern Design , 2020, Molecular informatics.

[56]  Jürgen Bajorath,et al.  Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values. , 2020, Journal of medicinal chemistry.

[57]  Xiaomin Luo,et al.  Pushing the boundaries of molecular representation for drug discovery with graph attention mechanism. , 2020, Journal of medicinal chemistry.

[58]  Gisbert Schneider,et al.  Drug discovery with explainable artificial intelligence , 2020, Nature Machine Intelligence.

[59]  Xin Chen,et al.  GCN-BMP: Investigating Graph Representation Learning for DDI Prediction Task. , 2020, Methods.

[60]  Shinichi Nakajima,et al.  Higher-Order Explanations of Graph Neural Networks via Relevant Walks , 2020, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[61]  Shuiwang Ji,et al.  XGNN: Towards Model-Level Explanations of Graph Neural Networks , 2020, KDD.

[62]  Arti Ramesh,et al.  RelEx: A Model-Agnostic Relational Model Explainer , 2020, AIES.

[63]  Hojung Nam,et al.  hERG-Att: Self-attention-based deep neural network for predicting hERG blockers , 2020, Comput. Biol. Chem..

[64]  Junzhou Huang,et al.  Dual Message Passing Neural Network for Molecular Property Prediction , 2020, ArXiv.

[65]  Fernando V. Paulovich,et al.  Explainable Matrix - Visualization for Global and Local Interpretability of Random Forest Classification Ensembles , 2020, IEEE Transactions on Visualization and Computer Graphics.

[66]  Michael Y. Kpiebaareh,et al.  Multi-View Self-Attention for Interpretable Drug-Target Interaction Prediction , 2020, J. Biomed. Informatics.

[67]  Dan Zhao,et al.  MONN: A Multi-objective Neural Network for Predicting Compound-Protein Interactions and Affinities , 2020, Cell Systems.

[68]  Talia B. Kimber,et al.  Revealing cytotoxic substructures in molecules using deep learning , 2020, Journal of Computer-Aided Molecular Design.

[69]  Thin Nguyen,et al.  Graph convolutional networks for drug response prediction , 2020, bioRxiv.

[70]  Kenichi Tanaka,et al.  Comparison and improvement of the predictability and interpretability with ensemble learning models in QSPR applications , 2020, Journal of Cheminformatics.

[71]  M. Mckee,et al.  Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. , 2020, JAMA.

[72]  Zhen Wu,et al.  A self-attention based message passing neural network for predicting molecular lipophilicity and aqueous solubility , 2020, Journal of Cheminformatics.

[73]  Mostafa Karimi,et al.  Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts , 2019, bioRxiv.

[74]  Ignacio Ponzoni,et al.  Neural-based approaches to overcome feature selection and applicability domain in drug-related property prediction , 2019, Appl. Soft Comput..

[75]  Suman K. Chakravarti,et al.  Descriptor Free QSAR Modeling Using Deep Learning With Long Short-Term Memory Neural Networks , 2019, Front. Artif. Intell..

[76]  Florian Leidner,et al.  Target-Specific Prediction of Ligand Affinity with Structure-Based Interaction Fingerprints , 2019, J. Chem. Inf. Model..

[77]  Amit Sharma,et al.  Explaining machine learning classifiers through diverse counterfactual explanations , 2019, FAT*.

[78]  Hossein Azizpour,et al.  Explainability Techniques for Graph Convolutional Networks , 2019, ICML 2019.

[79]  Jannis Born,et al.  Towards Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-based Convolutional Encoders , 2019, Molecular pharmaceutics.

[80]  J. Leskovec,et al.  GNNExplainer: Generating Explanations for Graph Neural Networks , 2019, NeurIPS.

[81]  Robert P Sheridan,et al.  Interpretation of QSAR Models by Coloring Atoms According to Changes in Predicted Activity: How Robust Is It? , 2019, J. Chem. Inf. Model..

[82]  Jianying Hu,et al.  Predicting adverse drug reactions through interpretable deep learning framework , 2018, BMC Bioinformatics.

[83]  Cynthia Rudin,et al.  Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead , 2018, Nature Machine Intelligence.

[84]  George Papadatos,et al.  Optimal Piecewise Linear Regression Algorithm for QSAR Modelling , 2018, Molecular informatics.

[85]  Isidro Cortes-Ciriano,et al.  Deep Confidence: A Computationally Efficient Framework for Calculating Reliable Errors for Deep Neural Networks , 2018, Journal of chemical information and modeling.

[86]  Matthias Rarey,et al.  Machine Learning in Drug Discovery , 2018, J. Chem. Inf. Model..

[87]  Tommi S. Jaakkola,et al.  Towards Robust Interpretability with Self-Explaining Neural Networks , 2018, NeurIPS.

[88]  Di Wu,et al.  DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks , 2018, bioRxiv.

[89]  Jonathan David,et al.  Interpretation of ANN‐based QSAR models for prediction of antioxidant activity of flavonoids , 2018, J. Comput. Chem..

[90]  Alexander Golbraikh,et al.  Multi-Descriptor Read Across (MuDRA): A Simple and Transparent Approach for Developing Accurate Quantitative Structure-Activity Relationship Models , 2018, J. Chem. Inf. Model..

[91]  Stefano Nembrini,et al.  The revival of the Gini importance? , 2018, Bioinform..

[92]  Hai Pham-The,et al.  Computational modeling of human oral bioavailability: what will be next? , 2018, Expert opinion on drug discovery.

[93]  Amit Dhurandhar,et al.  Explanations based on the Missing: Towards Contrastive Explanations with Pertinent Negatives , 2018, NeurIPS.

[94]  Franco Turini,et al.  A Survey of Methods for Explaining Black Box Models , 2018, ACM Comput. Surv..

[95]  Gianni De Fabritiis,et al.  KDEEP: Protein-Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks , 2018, J. Chem. Inf. Model..

[96]  David Weinberger,et al.  Accountability of AI Under the Law: The Role of Explanation , 2017, ArXiv.

[97]  Pavel Polishchuk,et al.  Interpretation of Quantitative Structure-Activity Relationship Models: Past, Present, and Future , 2017, J. Chem. Inf. Model..

[98]  Chris Russell,et al.  Counterfactual Explanations Without Opening the Black Box: Automated Decisions and the GDPR , 2017, ArXiv.

[99]  Anna Palczewska,et al.  Comparison of the Predictive Performance and Interpretability of Random Forest and Linear Models on Benchmark Data Sets , 2017, J. Chem. Inf. Model..

[100]  Tim Miller,et al.  Explanation in Artificial Intelligence: Insights from the Social Sciences , 2017, Artif. Intell..

[101]  Yarin Gal,et al.  Real Time Image Saliency for Black Box Classifiers , 2017, NIPS.

[102]  Scott Lundberg,et al.  A Unified Approach to Interpreting Model Predictions , 2017, NIPS.

[103]  Been Kim,et al.  Towards A Rigorous Science of Interpretable Machine Learning , 2017, 1702.08608.

[104]  Charles Blundell,et al.  Simple and Scalable Predictive Uncertainty Estimation using Deep Ensembles , 2016, NIPS.

[105]  Haralambos Sarimveis,et al.  Decision Trees for Continuous Data and Conditional Mutual Information as a Criterion for Splitting Instances. , 2016, Combinatorial chemistry & high throughput screening.

[106]  Carlos Guestrin,et al.  "Why Should I Trust You?": Explaining the Predictions of Any Classifier , 2016, ArXiv.

[107]  J. Burrell.  How the machine ‘thinks’: Understanding opacity in machine learning algorithms , 2016, Big Data Soc..

[108]  Alexander Binder,et al.  Explaining nonlinear classification decisions with deep Taylor decomposition , 2015, Pattern Recognit..

[109]  Virapong Prachayasittikul,et al.  Prediction of aromatase inhibitory activity using the efficient linear method (ELM) , 2015, EXCLI journal.

[110]  Eva Freyhult,et al.  A Machine Learning Approach to Explain Drug Selectivity to Soluble and Membrane Protein Targets , 2015, Molecular informatics.

[111]  Samuel J. Webb,et al.  Self organising hypothesis networks: a new approach for representing and structuring SAR knowledge , 2014, Journal of Cheminformatics.

[112]  Jun Hu,et al.  Determining molecular predictors of adverse drug reactions with causality analysis based on structure learning , 2014, J. Am. Medical Informatics Assoc..

[113]  Alexander Golbraikh,et al.  Integrative chemical-biological read-across approach for chemical hazard classification. , 2013, Chemical research in toxicology.

[114]  Lars Carlsson,et al.  Beyond the Scope of Free-Wilson Analysis: Building Interpretable QSAR Models with Machine Learning Algorithms , 2013, J. Chem. Inf. Model..

[115]  Kimito Funatsu,et al.  Atom Coloring for Chemical Interpretation and De Novo Design for Molecular Design , 2011 .

[116]  C. Murray,et al.  The rise of fragment-based drug discovery. , 2009, Nature chemistry.

[117]  James G. Nourse,et al.  Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..

[118]  Lars Kai Hansen,et al.  Neural Network Ensembles , 1990, IEEE Trans. Pattern Anal. Mach. Intell..

[119]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.

[120]  Yuting Xu,et al.  Deep Neural Networks for QSAR. , 2021, Methods in molecular biology.

[121]  OUP accepted manuscript , 2021, Bioinformatics.

[122]  Jamal Shamsara,et al.  A random forest model to predict the activity of a large set of soluble epoxide hydrolase inhibitors solely based on a set of simple fragmental descriptors. , 2019, Combinatorial chemistry & high throughput screening.

[123]  Apilak Worachartcheewan,et al.  Towards the Revival of Interpretable QSAR Models , 2017 .